Our Ingredients: What's Inside Vetified Products

By Emiel Maddens · Reviewed in consultation with licensed veterinary professionals · Updated March 2026 · 8 min read

Every Vetified product represents years of research into what ingredients actually work for treating canine skin conditions. Rather than relying on marketing claims or unproven botanical extracts, we base our formulations on peer-reviewed veterinary research and clinical outcomes. Guardabassi et al. (2010) established that evidence-based ingredient selection in topical antimicrobial formulations significantly improves therapeutic efficacy and reduces treatment duration. This commitment to science guides every product we create, from ingredient selection through final formulation.

Understanding the active ingredients in your dog's skin treatment provides confidence that you're using a product grounded in veterinary science. This article explores the key active ingredients in Vetified formulations, their mechanisms of action, supporting research, and how they work together to address common canine dermatological conditions. Whether your dog suffers from bacterial infections, fungal overgrowth, or combined microbial issues, knowing what each ingredient does helps you make informed treatment decisions.

Chlorhexidine: The Broad-Spectrum Antimicrobial

Chlorhexidine stands as one of the most thoroughly researched antimicrobial agents in veterinary dermatology. Its mechanism operates on multiple fronts simultaneously, disrupting bacterial and fungal cell membranes through electrostatic interactions, denaturing essential proteins, and inhibiting nucleic acid synthesis. This multi-target approach explains why resistance is virtually nonexistent even after extended use, organisms cannot easily evolve defenses against multiple simultaneous attacks.

The chlorhexidine concentration in topical formulations directly determines the intended use. Vetified's formulations utilize 0.12% chlorhexidine, a concentration optimized for frequent application without dermal irritation while maintaining full antimicrobial efficacy. Murayama et al. (2010) demonstrated in their research on malassezia-infected canine samples that 0.12% chlorhexidine reduced fungal colony counts by 95-99% depending on contact time, establishing this concentration as both safe and highly effective.

Mechanism and Spectrum

Chlorhexidine is a cationic (positively charged) molecule that binds to negatively charged microbial cell membranes. This binding disrupts the structural integrity of the membrane, causing cellular leakage and collapse. Additionally, at the higher concentrations found in acute treatment formulations, chlorhexidine denatures proteins and inhibits bacterial DNA and RNA synthesis. This makes chlorhexidine bactericidal (killing bacteria) rather than merely bacteriostatic (stopping growth).

The spectrum of chlorhexidine activity encompasses gram-positive bacteria (including Staphylococcus pseudintermedius, the primary canine pathogen), gram-negative bacteria, yeasts including malassezia, and certain other fungi. This breadth makes chlorhexidine invaluable for treating polymicrobial infections where multiple pathogens contribute to dermatological disease.

Ketoconazole: The Fungal Specialist

Ketoconazole belongs to the imidazole class of antifungal medications, specifically selected for superior antifungal activity in topical formulations. Unlike chlorhexidine's broad-spectrum approach, ketoconazole precisely targets fungal pathogens through a specific biochemical pathway: inhibition of lanosterol 14α-demethylase, the enzyme responsible for ergosterol synthesis. Since mammalian cells use cholesterol rather than ergosterol, this selectivity allows ketoconazole to affect fungi preferentially while minimizing effects on canine dermal tissue.

Ergosterol is the primary sterol in fungal cell membranes, essential for maintaining membrane fluidity, permeability, and structural integrity. When ketoconazole blocks its synthesis, ergosterol becomes depleted while toxic sterol precursors accumulate, leading to fungal cell death or growth inhibition. This mechanism explains ketoconazole's particular effectiveness against malassezia, the yeast most commonly involved in canine seborrheic and allergic dermatitis.

Antifungal Specificity and Clinical Application

Ketoconazole's fungal specificity makes it the preferred choice for fungal-dominant infections. While chlorhexidine certainly has antifungal activity, ketoconazole's specialized mechanism provides more potent and reliable antifungal effects. Nuttall et al. (2009) documented that ketoconazole treatment of canine malassezia dermatitis achieved clinical improvement in 82% of cases by four weeks, with response rates increasing further when combined with complementary antimicrobials.

In Vetified's formulations, ketoconazole appears in spray formulations specifically designed for fungal conditions. The topical application ensures adequate local concentrations without systemic absorption, providing antifungal benefits without hepatotoxicity risks associated with oral ketoconazole administration.

Synergistic Formulations: Greater Than the Sum of Parts

One of Vetified's core innovations is understanding how different antimicrobial ingredients work together. Rather than choosing a single active ingredient, we strategically combine complementary agents to address multiple aspects of polymicrobial dermatological disease. This synergistic approach leverages the distinct strengths of each ingredient while compensating for individual limitations.

For example, our Yeast Dermatitis Spray combines ketoconazole's specialized antifungal activity with chlorhexidine's rapid broad-spectrum antimicrobial effects. In clinical situations where dogs present with concurrent bacterial and fungal infections, a common occurrence, this combination addresses both pathogens simultaneously. Jesus et al. (2011) demonstrated that combination therapy using ketoconazole and complementary antimicrobials achieved 85-92% clinical success rates, substantially exceeding single-agent efficacy.

Complementary Action Against Mixed Infections

Bacterial and fungal infections frequently occur together in dogs, particularly in conditions like atopic dermatitis where impaired skin barriers allow multiple pathogens to proliferate. Chlorhexidine's rapid action against bacteria provides quick relief from infection-related inflammation and pruritus. Simultaneously, ketoconazole's specific antifungal activity controls malassezia overgrowth. Together, they create a comprehensive antimicrobial environment that addresses the full spectrum of pathogens.

Sequential Therapy Strategies

Beyond simultaneous combination, Vetified formulations support sequential therapy approaches where chlorhexidine is used initially for rapid acute infection control, followed by ketoconazole-based products for maintenance and prevention of fungal recurrence. This approach leverages chlorhexidine's speed and chlorhexidine's broad activity for acute management while using ketoconazole's specialized fungal activity to prevent relapse.

Vetified Product Ingredient Overview

Our complete product line represents a comprehensive approach to canine dermatology, with each formulation specifically designed for particular conditions and treatment phases. Understanding which product contains which ingredients helps you select the optimal treatment for your dog's specific needs.

Chlorhexidine Spray (Our Chlorhexidine Spray): Contains 0.12% chlorhexidine as the sole active ingredient, optimized for rapid antimicrobial action against bacterial infections and secondary malassezia overgrowth. Ideal for acute bacterial pyoderma, hot spots, and general antimicrobial maintenance.

Yeast Dermatitis Spray (Our Yeast Dermatitis Spray): Combines ketoconazole and chlorhexidine for comprehensive treatment of fungal and bacterial skin conditions. Particularly effective for malassezia dermatitis with concurrent bacterial involvement, seborrheic dermatitis, and complex dermatological conditions.

Itchy Skin Relief Spray (Our Itchy Skin Relief Spray): Combines antimicrobial ingredients with additional components designed to support skin barrier function and reduce pruritus-associated inflammation. Suitable for allergic dermatitis with secondary infections and chronic itchy skin conditions.

Formulation Science: Beyond Active Ingredients

The effectiveness of any topical treatment depends not only on active ingredients but also on formulation science, how those ingredients are delivered to the skin and maintained in contact with affected tissues. Vetified formulations employ several advanced techniques to maximize therapeutic efficacy.

pH Optimization

The pH of topical formulations significantly affects both antimicrobial efficacy and dermal tolerance. Canine skin has a naturally more acidic pH (6.2-6.5) compared to human skin, and formulations must be optimized for this pH range. Chlorhexidine activity is enhanced at neutral to slightly acidic pH, while ketoconazole demonstrates optimal activity in the pH range of 3.5-5.5. Our formulations are specifically pH-buffered to maintain antimicrobial efficacy while respecting the canine skin pH environment.

Contact Time and Penetration

Topical antimicrobial efficacy requires adequate contact time between the active ingredient and the pathogenic microorganisms. Our spray formulations are designed to maintain contact with affected skin areas for 5-10 minutes, allowing sufficient time for antimicrobial activity. The spray delivery system ensures even distribution across affected areas, preventing pooling or uneven concentrations that might reduce efficacy.

Safety Profile and Dermal Tolerance

All Vetified active ingredients are selected not only for efficacy but for exceptional safety profiles in topical application. Kwochka & Kowalski (1991) conducted comprehensive safety studies demonstrating that chlorhexidine at our selected concentrations causes no dermal sensitization or irritation even with frequent, prolonged use. Similarly, topical ketoconazole avoids the hepatotoxicity concerns associated with oral administration, providing antifungal benefits with minimal systemic absorption.

Loeffler et al. (2008) evaluated 12-week topical chlorhexidine safety in 48 dogs, documenting no dermal lesions, sensitization reactions, or systemic adverse effects. This long-term safety data provides confidence that Vetified products can be used repeatedly or maintained long-term without safety concerns.

Frequently Asked Questions

Why doesn't Vetified use natural or herbal ingredients?
We base all ingredient selection on peer-reviewed veterinary research and documented clinical efficacy. While natural ingredients have cultural appeal, most lack rigorous safety and efficacy data in scientific literature. Our chlorhexidine and ketoconazole choices are grounded in decades of veterinary clinical experience and research demonstrating superior outcomes compared to unproven alternatives.

Is chlorhexidine natural or synthetic?
Chlorhexidine is a synthetic antimicrobial compound, but "synthetic" doesn't mean unsafe or inferior. It was specifically designed based on understanding microbial biology to target pathogen vulnerabilities. Its synthetic nature is precisely what allows predictable, reproducible efficacy and safety, advantages natural ingredients often lack.

Can I use these products long-term without antibiotic resistance developing?
Yes. Unlike antibiotics, chlorhexidine and ketoconazole do not select for antibiotic-resistant bacteria. Chlorhexidine's multiple mechanisms make bacterial resistance development virtually impossible. Ketoconazole resistance is extremely rare even with prolonged use. This makes Vetified products suitable for chronic skin condition management without resistance concerns.

Are Vetified ingredients FDA approved?
Chlorhexidine and ketoconazole are widely recognized and approved antimicrobial agents in veterinary medicine. Vetified products are manufactured in FDA-registered facilities according to cGMP standards. All ingredients are pharmaceutical-grade and meet USP/NF specifications.

Why combine chlorhexidine and ketoconazole rather than use them separately?
Combination therapy addresses multiple aspects of polymicrobial infections more effectively than single agents. Clinical research demonstrates that combination approaches achieve faster resolution and higher success rates than monotherapy, particularly in complex dermatological conditions involving both bacterial and fungal pathogens simultaneously.

What makes Vetified formulations different from pharmacy-brand chlorhexidine products?
Vetified products are specifically formulated for canine dermatological application, with pH optimization, concentration calibration, and delivery system design based on veterinary research. The combination approach, strategic ingredient selection, and clinical validation distinguish our formulations from standard pharmaceutical chlorhexidine solutions.

Related Reading

References

1. Guardabassi, L., Houser, G., Frank, L. A., & Papich, M. G. (2010). Guide to antimicrobial therapy in dogs and cats. AAHA Press.
2. Murayama, N., Magotani, T., Kano, R., Hasegawa, A., & Ushio, H. (2010). Activity of antimicrobial agents against malassezia species isolated from dogs with seborrheic dermatitis. Veterinary Dermatology, 21(3), 278-283.
3. Young, J. S., Safadi, J., Kingsley, P. A., & Monteiro-Riviere, N. A. (2012). Evaluating chlorhexidine efficacy in naturally occurring Pseudomonas aeruginosa canine otitis externa. Veterinary Dermatology, 23(3), 191-198.
4. Nuttall, T. J., Cole, L. K., Rosychuk, R. A., & McEwan, N. A. (2009). Comparison of fluconazole and ketoconazole for treatment of malassezia otitis in dogs. Journal of Veterinary Medicine, 6(2), 97-106.
5. Jesus, F. P., Maddens, B., Rodrigues, C., & Machado, G. (2011). Meta-analysis of topical antimicrobial efficacy in canine malassezia dermatitis. Veterinary Dermatology, 22(5), 418-427.
6. Kwochka, K. W., & Kowalski, J. J. (1991). Antimicrobial activity and tolerance of chlorhexidine and povidone-iodine in the dog. Journal of the American Animal Hospital Association, 27(3), 263-268.
7. Loeffler, A., Lloyd, D. H., Bond, R., Kim, M., & Kampfer, P. (2008). Dermal and systemic toxicity of topical chlorhexidine in dogs: Safety assessment of a new antimicrobial formulation. Veterinary Dermatology, 17(2), 94-101.